Skip to main content
. 2020 Jun 15;2020:5798356. doi: 10.1155/2020/5798356

Table 3.

Neoepitope data included in this study.

Publication time PMID Author Tumor type Nonimmunogenic neoepitopes Immunogenic neoepitopes T-cell assay
2013-12 24323902 D. A. Wick et al. Ovarian cancer 1 ELISPOT
2015-9 26359337 E. M. Van Allen et al. Melanoma 18 Clinical benefit
2015-11 26752676 T. Karasaki et al. Lung adenocarcinoma 4
2016-1 26901407 A. Gros et al. Melanoma 12 14 ELISPOT
2016-5 27198675 E. Strønen, et al. Melanoma 1134 16 CTL clone
2016-12 28405493 A. Nelde et al. Lymphoma 2 ELISPOT
2017-6 28619968 X. Zhang et al. Breast cancer 4 Flow cytometry
2017-10 29104575 M. Markus et al. Melanoma 10 16
2017-11 29187854 A.-M. Bjerregaard et al. Polytype 1874 42 ELISPOT et al.
2017-11 29132146 V. P. Balachandran et al. Pancreatic 10 Flow cytometry
2018-5 29720506 T. Matsuda et al. Ovarian cancer 3 ELISPOT
2018-12 29409514 K. Sonntag et al. Pancreatic ductal carcinoma 3 Flow cytometry
2018-10 30357391 V. Randi et al. 6 35
Total 3030 168
Remove duplication 2837 164
Remove negative rank(%) > 2 and human 100% similar 1697 164